Petros Pharmaceuticals, Inc. (PTPI) › Operating IncomePetros Pharmaceuticals, Inc. (PTPI) — Operating IncomeAnnual figures by period end, from SEC filings.2020-12-31: -$17.28M2021-12-31: -$18.05M2022-12-31: -$19.92M2023-12-31: -$13.62M2024-12-31: -$4.63M2025-12-31: -$4.64M-$4.64M2020-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$4.64M—2026-04-15From 2025-01-012024-12-31-$4.63M—2026-04-15From 2024-01-012023-12-31-$13.62M—2025-03-31From 2023-01-012022-12-31-$19.92M—2024-04-01From 2022-01-012021-12-31-$18.05M—2023-03-31From 2021-01-012020-12-31-$17.28M—2022-03-31From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)